Thiazolyl MGLUR5 antagonists and methods for their use
The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the sel...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KING, CHRIS HUANG, DEHUA ROPPE, JEFFREY, R POON, STEVE, F PAYNE, JOSEPH EASTMAN, BRIAN, W ARRUDA, JEANNIE, M SMITH, NICHOLAS, D SEIDERS, THOMAS, J COSFORD, NICHOLAS, D VERNIER, JEAN-MICHEL ZHAO, XIUMIN WANG, BOWEI |
description | The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2380889B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2380889B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2380889B13</originalsourceid><addsrcrecordid>eNrjZDALychMrMrPqcxR8HX3CQ0yVUjMK0lMz8_LLC4pBrJTFHJTSzLyU4oV0vKLFEoyUjOLFEqLU3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgJGxhYGFhaWToTERSgAGPSyx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><source>esp@cenet</source><creator>KING, CHRIS ; HUANG, DEHUA ; ROPPE, JEFFREY, R ; POON, STEVE, F ; PAYNE, JOSEPH ; EASTMAN, BRIAN, W ; ARRUDA, JEANNIE, M ; SMITH, NICHOLAS, D ; SEIDERS, THOMAS, J ; COSFORD, NICHOLAS, D ; VERNIER, JEAN-MICHEL ; ZHAO, XIUMIN ; WANG, BOWEI</creator><creatorcontrib>KING, CHRIS ; HUANG, DEHUA ; ROPPE, JEFFREY, R ; POON, STEVE, F ; PAYNE, JOSEPH ; EASTMAN, BRIAN, W ; ARRUDA, JEANNIE, M ; SMITH, NICHOLAS, D ; SEIDERS, THOMAS, J ; COSFORD, NICHOLAS, D ; VERNIER, JEAN-MICHEL ; ZHAO, XIUMIN ; WANG, BOWEI</creatorcontrib><description>The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130626&DB=EPODOC&CC=EP&NR=2380889B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130626&DB=EPODOC&CC=EP&NR=2380889B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KING, CHRIS</creatorcontrib><creatorcontrib>HUANG, DEHUA</creatorcontrib><creatorcontrib>ROPPE, JEFFREY, R</creatorcontrib><creatorcontrib>POON, STEVE, F</creatorcontrib><creatorcontrib>PAYNE, JOSEPH</creatorcontrib><creatorcontrib>EASTMAN, BRIAN, W</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE, M</creatorcontrib><creatorcontrib>SMITH, NICHOLAS, D</creatorcontrib><creatorcontrib>SEIDERS, THOMAS, J</creatorcontrib><creatorcontrib>COSFORD, NICHOLAS, D</creatorcontrib><creatorcontrib>VERNIER, JEAN-MICHEL</creatorcontrib><creatorcontrib>ZHAO, XIUMIN</creatorcontrib><creatorcontrib>WANG, BOWEI</creatorcontrib><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><description>The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDALychMrMrPqcxR8HX3CQ0yVUjMK0lMz8_LLC4pBrJTFHJTSzLyU4oV0vKLFEoyUjOLFEqLU3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgJGxhYGFhaWToTERSgAGPSyx</recordid><startdate>20130626</startdate><enddate>20130626</enddate><creator>KING, CHRIS</creator><creator>HUANG, DEHUA</creator><creator>ROPPE, JEFFREY, R</creator><creator>POON, STEVE, F</creator><creator>PAYNE, JOSEPH</creator><creator>EASTMAN, BRIAN, W</creator><creator>ARRUDA, JEANNIE, M</creator><creator>SMITH, NICHOLAS, D</creator><creator>SEIDERS, THOMAS, J</creator><creator>COSFORD, NICHOLAS, D</creator><creator>VERNIER, JEAN-MICHEL</creator><creator>ZHAO, XIUMIN</creator><creator>WANG, BOWEI</creator><scope>EVB</scope></search><sort><creationdate>20130626</creationdate><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><author>KING, CHRIS ; HUANG, DEHUA ; ROPPE, JEFFREY, R ; POON, STEVE, F ; PAYNE, JOSEPH ; EASTMAN, BRIAN, W ; ARRUDA, JEANNIE, M ; SMITH, NICHOLAS, D ; SEIDERS, THOMAS, J ; COSFORD, NICHOLAS, D ; VERNIER, JEAN-MICHEL ; ZHAO, XIUMIN ; WANG, BOWEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2380889B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KING, CHRIS</creatorcontrib><creatorcontrib>HUANG, DEHUA</creatorcontrib><creatorcontrib>ROPPE, JEFFREY, R</creatorcontrib><creatorcontrib>POON, STEVE, F</creatorcontrib><creatorcontrib>PAYNE, JOSEPH</creatorcontrib><creatorcontrib>EASTMAN, BRIAN, W</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE, M</creatorcontrib><creatorcontrib>SMITH, NICHOLAS, D</creatorcontrib><creatorcontrib>SEIDERS, THOMAS, J</creatorcontrib><creatorcontrib>COSFORD, NICHOLAS, D</creatorcontrib><creatorcontrib>VERNIER, JEAN-MICHEL</creatorcontrib><creatorcontrib>ZHAO, XIUMIN</creatorcontrib><creatorcontrib>WANG, BOWEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KING, CHRIS</au><au>HUANG, DEHUA</au><au>ROPPE, JEFFREY, R</au><au>POON, STEVE, F</au><au>PAYNE, JOSEPH</au><au>EASTMAN, BRIAN, W</au><au>ARRUDA, JEANNIE, M</au><au>SMITH, NICHOLAS, D</au><au>SEIDERS, THOMAS, J</au><au>COSFORD, NICHOLAS, D</au><au>VERNIER, JEAN-MICHEL</au><au>ZHAO, XIUMIN</au><au>WANG, BOWEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiazolyl MGLUR5 antagonists and methods for their use</title><date>2013-06-26</date><risdate>2013</risdate><abstract>The identification of a unique series of 1,3 thiazoles which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP2380889B1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Thiazolyl MGLUR5 antagonists and methods for their use |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T05%3A32%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KING,%20CHRIS&rft.date=2013-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2380889B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |